Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Long-Term Debt Repayments (2016 - 2025)

Collegium Pharmaceutical has reported Long-Term Debt Repayments over the past 8 years, most recently at -$48.4 million for Q4 2025.

  • Quarterly results put Long-Term Debt Repayments at -$48.4 million for Q4 2025, down 400.0% from a year ago — trailing twelve months through Sep 2025 was $64.6 million (down 43.17% YoY), and the annual figure for FY2024 was $107.8 million, down 22.23%.
  • Long-Term Debt Repayments for Q4 2025 was -$48.4 million at Collegium Pharmaceutical, down from $16.1 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for COLL hit a ceiling of $113.6 million in Q2 2023 and a floor of -$48.4 million in Q4 2025.
  • Median Long-Term Debt Repayments over the past 5 years was $16.1 million (2024), compared with a mean of $20.4 million.
  • Biggest five-year swings in Long-Term Debt Repayments: skyrocketed 100.0% in 2022 and later plummeted 400.0% in 2025.
  • Collegium Pharmaceutical's Long-Term Debt Repayments stood at $12.5 million in 2021, then skyrocketed by 100.0% to $25.0 million in 2022, then decreased by 12.12% to $22.0 million in 2023, then decreased by 26.51% to $16.1 million in 2024, then plummeted by 400.0% to -$48.4 million in 2025.
  • The last three reported values for Long-Term Debt Repayments were -$48.4 million (Q4 2025), $16.1 million (Q3 2025), and $16.1 million (Q2 2025) per Business Quant data.